Table 2 Characteristics of n = 57 included studies and AGREE tool use
Characteristics | n (%) |
|---|---|
Type of included CPGs | |
All national/regional | 9 (16) |
Governmental | 3 (5) |
Topical | 41 (72) |
Professional society | 4 (7) |
Methods of CPG development | |
None mentioned | 47 (82) |
De novo | 5 (9) |
Adopt | 1 (2) |
Miscellaneous | 4 (7) |
Healthcare topic/area | |
Dermatology | 1 (2) |
Complementary and alternative medicine | 4 (7) |
Emergency medicine | 1 (2) |
Otolaryngology | 3 (5) |
“High priority diseases” | 2 (3.5) |
Internal medicine | 10 (17) |
Neurology | 2 (3.5) |
Nursing practice | 2 (3.5) |
Oncology | 2 (3.5) |
Orthopaedics | 4 (7) |
Paediatrics | 2 (3.5) |
Poverty-related | 1 (2) |
Primary care | 1 (2) |
Psychiatry | 2 (3.5) |
Surgery | 1 (2) |
Mixed | 19 (33) |
Strict inclusion criteria regarding the definition of a CPG | |
Yes | 21 (37) |
No | 36 (63) |
AGREE use | |
Used 2–4 assessors | 56 (98) |
Used overall assessment | 43 (74) |
Used one overall assessment only | 29 (69) |
Modified overall assessment | 24 (57) |